Search
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 598 items.
Health Canada is advising Canadians about unauthorized health products that may pose serious health risks. The table is updated when Health Canada finds unauthorized health products that are promoted for sexual enhancement, weight loss, as a workout aid…
AlertPublic advisory | 2022-05-25
Presence of an unspecified impurity near the acceptable concentration limit in the affected lot.
RecallHealth product recall | 2022-05-19
The assay is out of specification in the affected lot(s).
RecallHealth product recall | 2022-05-13
The complaint bottle contains Naphazolin HCl 0.013% and Glycern 0.26%.
RecallHealth product recall | 2022-05-09
Teva Canada Ltd. is recalling one lot each of Pharmasave Advanced Relief Eye Drops and Compliments Advanced Relief Eye Drops because of a packaging error. Some bottles may contain ingredients that are not listed on the label and that may pose health…
AlertPublic advisory | 2022-05-07
Presence of one (1) AA-FENO-SUPER 100 mg tablet in affected lot of AA-FENO-SUPER 160 mg.
RecallHealth product recall | 2022-05-05
Affected lot exceeds concentration limit for N-nitrosodimethylamine (NDMA).
RecallHealth product recall | 2022-04-28
Apotex Inc. is recalling certain lots of Apo-Acyclovir (acyclovir) tablets, in 200 mg and 800 mg strengths, due to the presence of a nitrosamine impurity (N-nitrosodimethylamine [NDMA]) above the acceptable level.
Apo-Acyclovir is a…
AlertPublic advisory | 2022-04-28
Health Canada is warning consumers not to use unauthorized health products seized from three herbal medicine stores in Calgary, Alberta, because they are labelled to contain prescription drugs and may pose serious health risks. The products include skin…
AlertPublic advisory | 2022-04-22
UPDATE: April 21, 2022 – Pfizer recalls Accupril blood pressure tablets due to a nitrosamine impurity
Pfizer Canada ULC is recalling all lots of the prescription drug Accupril (quinapril hydrochloride) in 10 mg, 20 mg and 40 mg strengths due to the…
AlertPublic advisory | 2022-04-21
Presence of N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-04-20
All lots contain undeclared Isopropyl Cloprostenate that is listed on the prescription drug list.
RecallHealth product recall | 2022-04-19
EVUSHELD (tixagevimab and cilgavimab for injection) was authorized by Health Canada on April 14, 2022. In order to provide rapid access to EVUSHELD in the context of the global COVID-19 pandemic, AstraZeneca will distribute product vials and cartons with…
AlertHealth professional risk communication | 2022-04-14
Health Canada is reminding Canadians of the risk of serious harm if children accidentally consume edible cannabis. Health Canada is aware of several cases of children being hospitalized, particularly after consuming products that are illegal and…
AlertPublic advisory | 2022-04-08
The Vial 1 assay may be out of specification in the affected lot(s).
RecallHealth product recall | 2022-03-24